TherapeuticsMD (TXMD) Net Margin (2011 - 2026)
TherapeuticsMD (TXMD) reported Net Margin of 1.1% for Q1 2026, up 322.0% on a YoY basis from 0.26% in Q1 2025, and down 40.96% quarter-over-quarter from 0.78% in Q4 2025.
TherapeuticsMD (TXMD) Net Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD has reported Net Margin for 16 years, with the latest figure at 1.1% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 322.0% year-over-year to 1.1%; the trailing twelve-month figure through Mar 2026 stood at 2.77% (up 66.0% YoY), and the FY2025 full-year result was 2.78%, down 466.0% from the prior year.
- Net Margin for Q1 2026 stood at 1.1%, down from 0.78% in the prior quarter.
- The five-year high for Net Margin was 36538.51% in Q2 2022, with the low at 4481.44% in Q1 2022.
- Historically, Net Margin has averaged 1514.39% across 5 years, with a median of 0.94% in 2025.
- The largest YoY upside for Net Margin was 3672394 bps in 2022 against a maximum downside of 428320 bps in 2022.
- TherapeuticsMD's Net Margin stood at 42.66% in 2022, then surged by 207 bps to 131.08% in 2023, then slumped by 84 bps to 20.69% in 2024, then slumped by 104 bps to 0.78% in 2025, then tumbled by 41 bps to 1.1% in 2026.
- The last three Net Margin figures came in at 1.1% (Q1 2026), 0.78% (Q4 2025), and 13.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - | -1.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.10% |
| Dec 31, 2025 | -0.78% |
| Sep 30, 2025 | 13.01% |
| Jun 30, 2025 | 0.63% |
| Mar 31, 2025 | -4.33% |
| Dec 31, 2024 | 20.69% |
| Sep 30, 2024 | -7.68% |
| Jun 30, 2024 | -17.09% |
| Mar 31, 2024 | 23.96% |
| Dec 31, 2023 | 131.08% |
| Sep 30, 2023 | -3,667.92% |
| Mar 31, 2023 | -310.82% |
| Dec 31, 2022 | 42.66% |
| Sep 30, 2022 | -4,049.15% |
| Jun 30, 2022 | 36,538.51% |
| Mar 31, 2022 | -4,481.44% |
| Dec 31, 2021 | 268.50% |
| Sep 30, 2021 | -186.65% |
| Jun 30, 2021 | -185.44% |
| Mar 31, 2021 | -198.24% |